This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...